Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | BRD2 | P25440 | 2/20 | 0.30 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL13736198 | 0.77 | — | — | |
| SCHEMBL14664134 | 0.67 | ALDH1A1 (0.44) | KMT2AALDH1A1TSHRL3MBTL1LMNA | |
| SCHEMBL1124487 | 0.65 | GAA (0.49) | BRD4KMT2AALDH1A1TSHRL3MBTL1 | |
| SCHEMBL1124489 | 0.65 | GAA (0.49) | BRD4KMT2AALDH1A1TSHRL3MBTL1 | |
| SCHEMBL96416 | 0.65 | — | — | |
| Pivalate SCHEMBL25243131 | 0.61 | CA1 (0.43) | ALDH1A1TSHR | |
| Pivalate SCHEMBL2204587 | 0.61 | CA1 (0.43) | ALDH1A1TSHR | |
| Pivalate SCHEMBL1043179 | 0.61 | — | — | |
| Pivalate SCHEMBL2349136 | 0.61 | — | — | |
| Pivalate SCHEMBL101921 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2655382-B1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2022-09-28 | — | — | EP | disclosed |
| CN-108586500-B | Zinc coordination complex and method for preparing organic zinc reagent | 慕尼黑路德维希马克西米利安斯大学 | 2021-06-25 | — | — | CN | disclosed |
| US-9273070-B2 | Organozinc complexes and processes for making and using the same | KNOCHEL PAUL (DE) | 2016-03-01 | — | — | US | disclosed |
| US-20140031545-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | LUDWIG-MAXIMILIAN-UNIVERSITAT MUNCHEN (DE) | 2014-01-30 | — | — | US | disclosed |
| EP-2655382-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | Ludwig-Maximilians-Universität München (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012085168-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2012-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140031545-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | ODC1, AOC1, ADH1C | BRD4 646/4885KMT2A 167/4885ALDH1A1 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.